EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe

Stavros Melemenidis iD, James C Knight iD, Veerle Kersemans, Francisco Perez-Balderas, Niloufar Zarghami, Manuel Sarmiento Soto, Bart Cornelissen, Ruth J Muschel, Nicola R Sibson iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Stavros Melemenidis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford School of Medicine, Cancer Institute, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Vascular Cell Adhesion Molecule-1, Lung Neoplasms, Magnetic Resonance Imaging, Contrast Media. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, CR-UK & EPSRC Oxford Cancer Imaging Center, CR-UK & EPSRC Oxford Cancer Imaging Centre Studentship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current clinical diagnostic imaging methods for lung metastases are sensitive only to large tumours (1–2 mm cross-sectional diameter), and early detection can dramatically improve treatment. We have previously demonstrated that an antibody-targeted MRI contrast agent based on microparticles of iron oxide (MPIO; 1 μm diameter) enables the imaging of endothelial vascular cell adhesion molecule-1 (VCAM-1). Using a mouse model of lung metastasis, upregulation of endothelial VCAM-1 expression was demonstrated in micrometastasis-associated vessels but not in normal lung tissue, and binding of VCAM-MPIO to these vessels was evident histologically. Owing to the lack of proton MRI signals in the lungs, we modified the VCAM-MPIO to include zirconium-89 (89Zr, t1/2 = 78.4 h) in order to allow the in vivo detection of lung metastases by positron emission tomography (PET). Using this new agent (89Zr-DFO-VCAM-MPIO), it was possible to detect the presence of micrometastases within the lung in vivo from ca. 140 μm in diameter. Histological analysis combined with autoradiography confirmed the specific binding of the agent to the VCAM-1 expressing vasculature at the sites of pulmonary micrometastases. By retaining the original VCAM-MPIO as the basis for this new molecular contrast agent, we have created a dual-modality (PET/MRI) agent for the concurrent detection of lung and brain micrometastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Cell Adhesion Molecule-1Lung NeoplasmsMagnetic Resonance ImagingContrast MediaPositron-Emission TomographyZirconiumAnimalsMiceNeoplasm MicrometastasisFerric CompoundsHumansCell Line, TumorRadioisotopes

Stichwörter der Autor:innen

dual modality (PET/MRI)early detectionmicrometastasismicroparticles of iron oxide (MPIO)vascular cell adhesion molecule-1 (VCAM-1)

Substanzen

Vascular Cell Adhesion Molecule-1Contrast MediaZirconiumZirconium-89Ferric Compoundsferric oxideRadioisotopes

Autor:innen und Institutionen

  • Department of Radiation Oncology, Stanford School of Medicine, Cancer Institute, Stanford University, Stanford, CA 94305, USA.
  • School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
  • Clinical Nuclear Medicine Imaging, Siemens Healthineers, 2595 BN The Hague, The Netherlands.
  • CureVac, AG. Paul-Ehrlich-Str. 15, 72076 Tubingen, Germany.
  • Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
  • Department of Biochemistry and Molecular Biology, University of Seville, 41004 Seville, Spain.

ORCID-Profile: Stavros Melemenidis, James C Knight, Nicola R Sibson

Förderung

  • Cancer Research UK
  • CR-UK & EPSRC Oxford Cancer Imaging Center
  • CR-UK & EPSRC Oxford Cancer Imaging Centre Studentship

Zitieren

APA

Melemenidis, S., Knight, J. C., Kersemans, V., Perez-Balderas, F., Zarghami, N., Soto, M. S., Cornelissen, B., Muschel, R. J., & Sibson, N. R. (2024). In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137160

Vancouver

Melemenidis S, Knight JC, Kersemans V, Perez-Balderas F, Zarghami N, Soto MS, et al. In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137160

BibTeX
@article{Melemenidis2024,
  author = {Melemenidis, Stavros and Knight, James C and Kersemans, Veerle and Perez-Balderas, Francisco and Zarghami, Niloufar and Soto, Manuel Sarmiento and Cornelissen, Bart and Muschel, Ruth J and Sibson, Nicola R},
  title = {In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137160}
}
Kostenlos starten →